Trade Margins Capped at 30% on 137 Cancer Drugs in India
The Indian government has capped trade margins at 30% of the MRP on 137 cancer drugs, covering over 1,000 medicine brands. This move aims to reduce costs for patients, but effective implementation and monitoring are essential to ensure that the price cap results in lower medical bills for cancer treatment.
TOI Business·



